13171951 · Active · incorporated 5 years, 8 months ago · London
Biotech AI Biotech & Life Sciences Deep Tech Drug Discovery Series B+
CoSyne Therapeutics is an AI drug discovery company focused on precision medicine, using polymathic AI to accelerate drug development.
Cosyne Therapeutics Limited is a private limited company registered at Companies House under number 13171951, incorporated on 1 February 2021, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 44 filings for this company, including 4 funding rounds. Its most recent round closed in July 2026, raising £8.1m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 4 | Jul 2026 | £8.1m | £2.07 |
| Round 3 | Aug 2024 | £3.3m | £3.36 |
| Round 2 | May 2022 | £5.9m | £3.39 |
| Round 1 | May 2022 | £302k | £3.39 |
Showing the 10 most recent of 44 filings.
See the complete cap table with every shareholder, founder tags, dilution across 10 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.